Medsafe Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 06-12-2024
- Paid Up Capital ₹ 1.13 M
as on 06-12-2024
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.80 M
as on 06-12-2024
- Revenue 1057.46%
(FY 2018)
- Profit 175.66%
(FY 2018)
- Ebitda 235.37%
(FY 2018)
- Net Worth 205.44%
(FY 2018)
- Total Assets 1443.85%
(FY 2018)
About Medsafe Pharmaceuticals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.13 M.
The company currently has active open charges totaling ₹1.80 M.
The Key Managerial Personnel (KMP) at Medsafe Pharmaceuticals Private Limited India is Senbhadra Thakur as CEO. Senbhadra Thakur and Bindu Thakur serve as directors at the Company.
- CIN/LLPIN
U33130MH2016PTC282293
- Company No.
282293
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jun 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Raigarh, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Medsafe Pharmaceuticals Private Limited offer?
Medsafe Pharmaceuticals Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Blood Pressure Medicine, Antacid Drugs, Rabeprazole Domperidone Capsule, Pharmaceutical Syrup, Oral Suspension, API (Active Pharmaceutical Ingredients), Montelukast Sodium Powder, Esomeprazole Drugs, Esomeprazole and Domperidone Tablets.
Who are the key members and board of directors at Medsafe Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Senbhadra Thakur  | CEO | 13-Jun-2016 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Senbhadra Thakur | Director and Ceo | 13-Jun-2016 | Current |
| Bindu Thakur | Director | 27-Mar-2017 | Current |
Financial Performance of Medsafe Pharmaceuticals.
Medsafe Pharmaceuticals Private Limited, for the financial year ended 2018, experienced significant growth in revenue, with a 1057.46% increase. The company also saw a substantial improvement in profitability, with a 175.66% increase in profit. The company's net worth Soared by an impressive increase of 205.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medsafe Pharmaceuticals?
In 2018, Medsafe Pharmaceuticals had a promoter holding of 51.00% and a public holding of 49.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 05 Jun 2020 | ₹0.30 M | Open |
Others Creation Date: 28 Jul 2017 | ₹1.50 M | Open |
How Many Employees Work at Medsafe Pharmaceuticals?
Unlock and access historical data on people associated with Medsafe Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medsafe Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medsafe Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
